Global Praziquantel Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Praziquantel Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Praziquantel (PZQ), sold under the brandname Biltricide among others, is a medication used to treat a number of types of parasitic worm infections. Specifically it is used for schistosomiasis, clonorchiasis, opisthorchiasis, tapeworm infections, cysticercosis, hydatid disease, and other fluke infections. It should not be used for worm infections of the eye.
Praziquantel report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Praziquantel market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Cestode Infections and Cysticercosis are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Praziquantel industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Praziquantel key manufacturers include Bayer, Zoetis, Richter Pharma, Chanelle Pharma, Covetrus, Shin Poong Pharm, Merial, Norbrook Laboratories and AniMedica, etc. Bayer, Zoetis, Richter Pharma are top 3 players and held % sales share in total in 2022.
Praziquantel can be divided into Patent and Generic, etc. Patent is the mainstream product in the market, accounting for % sales share globally in 2022.
Praziquantel is widely used in various fields, such as Cestode Infections, Cysticercosis, Liver Fluke Infection and Trematode Infections, etc. Cestode Infections provides greatest supports to the Praziquantel industry development. In 2022, global % sales of Praziquantel went into Cestode Infections filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Praziquantel market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Bayer
Zoetis
Richter Pharma
Chanelle Pharma
Covetrus
Shin Poong Pharm
Merial
Norbrook Laboratories
AniMedica
Kyron Pharma
Ecuphar
Lavet Pharmaceuticals
Krka
Auvex
Mavlab Animal Health
Ceva Santé Animale
Soparfin
C and H Generics
CiplaVet
Merck
Segment by Type
Patent
Generic
Cestode Infections
Cysticercosis
Liver Fluke Infection
Trematode Infections
Schistosoma Infection
Others
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Praziquantel market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Praziquantel, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Praziquantel industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Praziquantel in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Praziquantel introduction, etc. Praziquantel Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Praziquantel market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Praziquantel report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Praziquantel market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Cestode Infections and Cysticercosis are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Praziquantel industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Praziquantel key manufacturers include Bayer, Zoetis, Richter Pharma, Chanelle Pharma, Covetrus, Shin Poong Pharm, Merial, Norbrook Laboratories and AniMedica, etc. Bayer, Zoetis, Richter Pharma are top 3 players and held % sales share in total in 2022.
Praziquantel can be divided into Patent and Generic, etc. Patent is the mainstream product in the market, accounting for % sales share globally in 2022.
Praziquantel is widely used in various fields, such as Cestode Infections, Cysticercosis, Liver Fluke Infection and Trematode Infections, etc. Cestode Infections provides greatest supports to the Praziquantel industry development. In 2022, global % sales of Praziquantel went into Cestode Infections filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Praziquantel market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Bayer
Zoetis
Richter Pharma
Chanelle Pharma
Covetrus
Shin Poong Pharm
Merial
Norbrook Laboratories
AniMedica
Kyron Pharma
Ecuphar
Lavet Pharmaceuticals
Krka
Auvex
Mavlab Animal Health
Ceva Santé Animale
Soparfin
C and H Generics
CiplaVet
Merck
Segment by Type
Patent
Generic
Segment by Application
Cestode Infections
Cysticercosis
Liver Fluke Infection
Trematode Infections
Schistosoma Infection
Others
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Praziquantel market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Praziquantel, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Praziquantel industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Praziquantel in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Praziquantel introduction, etc. Praziquantel Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Praziquantel market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.